Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Seventure goes with its gut for funding focus

This article was originally published in Clinica

Executive Summary

With a rapid increase of research into the human microbiome, Seventure continues to attract investors into its Health for Life Capital Fund. Since launching the fund in December 2013, Seventure has raised a total of €100m ($105m) to back microbiome-focused businesses in the pharmaceutical and nutrition sectors. The latest €25m tranche edges the French venture capitalist closer to its €120m target.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts